Company Filing History:
Years Active: 2010
Title: Tomohisa Ninomiya: Innovator in Therapeutic Agents for Inflammatory Bowel Diseases
Introduction
Tomohisa Ninomiya is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicine, particularly in the development of therapeutic agents for inflammatory bowel diseases. His innovative approach has the potential to improve treatment outcomes for patients suffering from these conditions.
Latest Patents
Ninomiya holds a patent for a therapeutic agent aimed at treating inflammatory bowel diseases. The patent describes a method for maintaining remission or treating these diseases by administering a therapeutically effective amount of 7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzoazepine, or its prodrug. This method is particularly effective in maintaining therapy and has minimal side effects, even in severe cases resistant to conventional treatments. He has 1 patent to his name.
Career Highlights
Ninomiya is associated with Meiji Seika Kaisha, Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing effective treatments that can significantly enhance the quality of life for patients with chronic conditions.
Collaborations
Throughout his career, Ninomiya has collaborated with esteemed colleagues such as Takashi Shishikura and Mitsuhiro Uchida. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tomohisa Ninomiya's work in developing therapeutic agents for inflammatory bowel diseases showcases his commitment to advancing medical science. His innovative methods and collaborations highlight the importance of research in improving patient care.